ECE2015 Eposter Presentations Thyroid cancer (90 abstracts)
Female male ratio in thyroid cancer
Sevilay Ozmen 1 , Ilknur Calik 1 , Aynur Arslan 1 , Ozge Timur 2 , Hakan Sevimli 2 , Ayse Carlioglu 3 , Senay Arikan Durmaz 3 , Ali Kurt 1 & Fazli Erdogan 1
1Department of Pathology, Training and Research Hospital, Erzurum, Turkey; 2Department of Internal Medicine, Training and Research Hospital, Erzurum, Turkey; 3Department of Endocrinology, Training and Research Hospital, Erzurum, Turkey.
Aim: 402 patients who were admitted and FNA was done in the Endocrinology Clinic at EBEAH were enrolled in this study. 340 (85%) of them were females and 62 (15%) of them were males. The age range was between 16 and 82. There weren’t any statistical differences in age between both sexes. Thyroid cancer is reported to constitute <2% of cancers in humans. At the same time, it is the most lethal endocrine malignancy. In the literature it is stated that 3% of all cancers in women and 1% of all cancers in men is thyroid cancer. Papillary thyroid carcinoma is the most common malignant neoplasm of thyroid, it generates ~80% of all thyroid cancers.
Results: 340 of the examined 402 cases were female and cytopathological results of 303 (89.11%) were benign, 37 (10.88%) were malignant. A total of 62 male patients, 55 (88.70%) were benign, 7 (11.29%) were malignant. Totally 358 cases were reported as benign, 44 cases were reported as malignant. Of the 37 patients who were female, 26 had malignant papillary carcinoma, eight had papillary microcarcinoma, and three had follicular carcinoma. Of the seven male cases which were histopathologically reported as malignant, four had papillary carcinoma, two had papillary microcarcinoma, and one of them was reported as a well-differentiated neoplasm of uncertain malignant potential. When the results of FNAB were analysed according to the gender distribution, there wasn’t any statistically significant difference. The results of FNAB were reported as benign in 89.11% of female and 88.70% of male patients. The positive assessment in terms of malignancy were 10.88% in females and 11.29% in males. Although, some malignancies are more common in women and some in men, thyroid malignancies can develop at any gender. In this study which includes 402 cases there was no significant difference in terms of gender. And these findings are very close to the values reported in the literature.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more